tion.
The new antibiotic myxothiazol ( Fig. 1) is produced by the myxobacterium Myxococcus fulvus strain Mx f16. The production and isolation of the compound, some of its biological and physicochemical properties, and its chemical structure have been described recently (2, 6) . In this article we report on the mode of action of the antibiotic.
MATERIALS AND METHODS
Organisms. The experimental strains were from the Deutsche Sammlung von Mikroorganismen (DSM) in Gottingen, West Germany; the Centraalbureau voor Schimmelcultures (CBS) in Baarn, The Netherlands; the American Type Culture Collection (ATCC) in Bethesda, Md.; the Institut fur Biologie II of the University of Tubingen, (Tu), Tubingen, West Germany; or our own collection (GBF).
MIC. The minimum inhibitory concentrations (MICs) of myxothiazol were determined in liquid cultures by a serial dilution assay with dilution steps of 1: 2. The organisms were grown in test tubes containing 3 All yeasts and fungi were inhibited by myxothiazol at low to very low concentrations ( Table  2 ). The three basidiomycetes could be tested only in plate cultures and were relatively resistant to the antibiotic ( Table 3) .
Effect of myxothiazol on viability of C. albicans. When myxothiazol was added to a log-phase culture, the yeast cells completely stopped multiplication for about 4 h. After this time there was a slow increase in colony-forming units for several hours. This increase was consistently more pronounced with 25.0 ,ug than with 6.2 ,Ag of myxothiazol per ml (Fig. 2) .
Antagonistic effect of glucose. In the presence of glucose, myxothiazol had no inhibitory effect on C. albicans (Fig. 3) . When glucose was added to a culture which had been blocked before with myxothiazol, growth was resumed after a delay of a few hours. This glucose-myxothiazol antagonism could also be demonstrated with S. cerevisiae and M. hiemalis. Effect of myxothiazol on the respiration of C. albicans. The antibiotic inhibited oxygen consumption by starved yeast cells fairly efficiently. The dose of myxothiazol required to inhibit the respiration of 108 cells, suspended in 1 ml, by 50 and 90% was 0.3 and 30 ,ug, respectively (Fig. 4) .
DISCUSSION
The action of the new antibiotic myxothiazol was essentially restricted to eucaryotic cells. In addition to the inhibitory effect for yeasts and fungi as reported in this article and elsewhere (2), high toxicity has also been demonstrated for chicken embryo fibroblasts, ascites cells, and whole animals (mice) (2) . Among the bacteria tested, only a few gram-positive organisms responded to the antibiotic. In contrast to a previous statement (2), we found that all yeasts were very susceptible to myxothiazol. The ex- (2) .
The differences in susceptibility found with different organisms could be due to permeability barriers or to chemical modification of the antibiotic by some of the organisms. Another explanation would be the existence of resistant respiratory pathways or of bypasses of the blocked reaction step. Alternative antimycin-and KCN- 
